Table 1.
Subject characteristics
| Control (n = 5 M/15 F) | SARS-CoV-2 (n = 4 M/7 F) | Control (n = 5 M) | SARS-CoV-2 (n = 4 M) | Control (n = 15 F) | SARS-CoV-2 (n = 7 F) | |
|---|---|---|---|---|---|---|
| Age, yr | 23.0 ± 1.3 | 20.1 ± 1.1* | 22.6 ± 1.1 | 20.8 ± 0.5 | 23.2 ± 1.3 | 19.9 ± 1.2 |
| Height, cm | 167.4 ± 9.3 | 171.5 ± 11.9 | 179.3 ± 7.4 | 182.2 ± 7.0 | 163.4 ± 7.3 | 165.4 ± 9.4 |
| Weight, kg | 63.0 ± 7.4 | 69.5 ± 12.4 | 66.8 ± 7.0 | 75.1 ± 8.1 | 61.8 ± 7.3 | 66.3 ± 13.8 |
| BMI, kg/m2 | 22.5 ± 2.2 | 23.5 ± 2.9 | 20.8 ± 1.7 | 22.5 ± 1.1 | 23.1 ± 2.1 | 24.1 ± 3.5 |
| Supine systolic arterial pressure, mmHg | 111.8 ± 13.4 | 121.3 ± 12.3 | 114.2 ± 11.2 | 122.0 ± 13.5 | 110.9 ± 14.5 | 120.9 ± 12.7 |
| Supine diastolic arterial pressure, mmHg | 77.7 ± 7.7 | 71.8 ± 7.1 | 79.0 ± 12.0 | 68.6 ± 6.5 | 77.2 ± 6.0 | 73.6 ± 7.3 |
| Supine mean arterial pressure, mmHg | 89.9 ± 7.5 | 88.3 ± 8.2 | 90.8 ± 9.6 | 86.4 ± 8.4 | 91.4 ± 9.5 | 89.4 ± 8.6 |
| Physical activity frequency, day/wk | 4.1 ± 1.5 | 3.6 ± 1.2 | 5.4 ± 1.8 | 3.0 ± 0.8 | 3.7 ± 1.1 | 3.9 ± 1.4 |
| Physical activity duration, min/day | 44.3 ± 14.4 | 38.9 ± 12.5 | 51.0 ± 12.3 | 37.5 ± 12.3 | 42.0 ± 14.7 | 39.6 ± 13.5 |
| Oral contractive use, % females | 75 | 71 | ||||
| Number of symptoms | 2.9 ± 2.3 | 2.8 ± 1.0 | 3.0 ± 2.9 | |||
| Average symptom severity, 0–100 | 15.0 ± 12.2 | 13.0 ± 6.9 | 16.1 ± 14.9 |
Values are means ± SD; two-tailed Student’s t tests for two samples of equal variance were performed between control (n = 5 M/15 F) and SARS-CoV-2 (n = 4 M/7 F) groups. BMI: body mass index.
*P < 0.01, between groups.